ASR Vermogensbeheer N.V. Sells 226 Shares of Agilent Technologies, Inc. $A

ASR Vermogensbeheer N.V. lessened its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 0.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 55,414 shares of the medical research company’s stock after selling 226 shares during the period. ASR Vermogensbeheer N.V.’s holdings in Agilent Technologies were worth $6,539,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Generation Investment Management LLP boosted its holdings in shares of Agilent Technologies by 19.8% in the 1st quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company’s stock valued at $582,976,000 after purchasing an additional 824,243 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Agilent Technologies by 18.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock valued at $448,748,000 after purchasing an additional 604,124 shares in the last quarter. Mackenzie Financial Corp boosted its holdings in shares of Agilent Technologies by 141.5% in the 1st quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company’s stock valued at $109,481,000 after purchasing an additional 548,344 shares in the last quarter. Woodline Partners LP boosted its holdings in shares of Agilent Technologies by 681.6% in the 1st quarter. Woodline Partners LP now owns 522,073 shares of the medical research company’s stock valued at $61,072,000 after purchasing an additional 455,276 shares in the last quarter. Finally, Parnassus Investments LLC boosted its holdings in shares of Agilent Technologies by 38.3% in the 1st quarter. Parnassus Investments LLC now owns 1,577,999 shares of the medical research company’s stock valued at $184,594,000 after purchasing an additional 437,242 shares in the last quarter.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on A shares. Wall Street Zen downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a report on Friday, September 5th. Robert W. Baird raised their target price on Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a report on Thursday, August 28th. Evercore ISI reduced their target price on Agilent Technologies from $130.00 to $128.00 and set an “in-line” rating on the stock in a report on Thursday, August 28th. Wells Fargo & Company upped their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a report on Monday, September 15th. Finally, Barclays upped their price target on shares of Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a report on Thursday. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $142.17.

Agilent Technologies Stock Up 0.1%

Shares of NYSE:A opened at $138.66 on Friday. The company has a fifty day moving average of $122.36 and a 200-day moving average of $116.28. The company has a market capitalization of $39.31 billion, a PE ratio of 32.55, a price-to-earnings-growth ratio of 4.52 and a beta of 1.26. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.37. The business had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.Agilent Technologies’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same period last year, the company earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be given a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies’s dividend payout ratio (DPR) is currently 23.24%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.